Robert Young Kim - Net Worth and Insider Trading

Robert Young Kim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Young Kim owns 1 companies in total, including 4D Molecular Therapeutics Inc (FDMT) .

Click here to see the complete history of Robert Young Kim’s form 4 insider trades.

Insider Ownership Summary of Robert Young Kim

Ticker Comapny Transaction Date Type of Owner
FDMT 4D Molecular Therapeutics Inc 2023-03-24 Chief Medical Officer

Robert Young Kim Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Young Kim Ownership Network

Ownership Network List of Robert Young Kim

No Data

Ownership Network Relation of Robert Young Kim

Robert Young Kim Owned Company Details

What does 4D Molecular Therapeutics Inc do?

4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built portfolio of gene therapy product candidates focused in three therapeutic areas: ophthalmology (intravitreal vector), cardiology (intravenous vector) and pulmonology (aerosol vector). It has three product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa in a Phase 1/2 clinical trial, 4D-110 for the treatment of choroideremia in a Phase 1 clinical trial, and 4D-310 for the treatment of Fabry disease in a Phase 1/2 clinical trial. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration, and 4D-710 for the treatment of cystic fibrosis lung disease.

Who are the key executives at 4D Molecular Therapeutics Inc?

Robert Young Kim is the Chief Medical Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include 10 percent owner Viking Global Opportunities Parent Gp Llc , 10 percent owner Viking Global Investors Lp , and 10 percent owner Ole Andreas Halvorsen .

4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary

Over the past 18 months, Robert Young Kim made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 140,847 shares made by David Kirn , a net sale of 11,998 shares made by Scott Bizily , and a net purchase of 850,000 shares made by Viking Global Investors Lp .

In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 157,845 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 692,155 shares.

4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.


4D Molecular Therapeutics Inc Insider Transactions

No Available Data

Robert Young Kim Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Young Kim. You might contact Robert Young Kim via mailing address: C/o 4d Molecular Therapeutics, Inc., 5858 Horton Street #455, Emeryville Ca 94608.

Discussions on Robert Young Kim

No discussions yet.